Literature DB >> 17074494

Ring substituent effects on biological activity of vinyl sulfones as inhibitors of HIV-1.

D Christopher Meadows1, Tino Sanchez, Nouri Neamati, Thomas W North, Jacquelyn Gervay-Hague.   

Abstract

In a previous study, we prepared a small library of chicoric acid analogs that possessed both potent anti-integrase and antiviral activity. It was also shown that active compounds fell into one of two groups: those that inhibited an early stage in viral replication and those that inhibited at a later stage. In this study, a series of vinyl geminal disulfone-containing compounds possessing a range of ring substituents has been synthesized to probe the impact of structure on inhibitory mechanisms. Four active compounds were identified using HIV drug susceptibility assays. Three of the inhibitors possessing either no substituents or electron-withdrawing substituents on the aromatic rings led to high levels of cytotoxicity and antiviral activity. Intrigued by the potential implications of electronic effects on activity, we probed whether the active compounds could be nonspecifically reacting via 1,4-addition. To investigate this hypothesis, the compounds were incubated with glutathione and upon LC/MS analysis, molecular ion peaks corresponding to both mono and double addition adducts were identified. Second, we synthesized analogs lacking the ability to participate in 1,4-addition and tested them for antiviral activity and cytotoxicity, and found the compounds inactive for both activities. Taken together, the studies reported herein suggest that compounds lacking electron-donating substituents on the aromatic ring are promiscuous acceptors of biological nucleophiles, whereas compounds possessing electron-donating substituents seem to resist addition or at least be more selective and significantly less toxic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074494      PMCID: PMC1994090          DOI: 10.1016/j.bmc.2006.10.017

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

1.  Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study.

Authors:  S Duwe; M Brunn; D Altmann; O Hamouda; B Schmidt; H Walter; G Pauli; C Kücherer
Journal:  J Acquir Immune Defic Syndr       Date:  2001-03-01       Impact factor: 3.731

2.  Novel syntheses of cis and trans isomers of combretastatin A-4.

Authors:  K Gaukroger; J A Hadfield; L A Hepworth; N J Lawrence; A T McGown
Journal:  J Org Chem       Date:  2001-11-30       Impact factor: 4.354

Review 3.  HIV integrase, a brief overview from chemistry to therapeutics.

Authors:  R Craigie
Journal:  J Biol Chem       Date:  2001-05-09       Impact factor: 5.157

Review 4.  Rates of transmission of antiretroviral drug resistant strains of HIV-1.

Authors:  Palanee Ammaranond; Philip Cunningham; Robert Oelrichs; Kazuo Suzuki; Claire Harris; Leakhena Leas; Andrew Grulich; David A Cooper; Anthony D Kelleher
Journal:  J Clin Virol       Date:  2003-02       Impact factor: 3.168

5.  Inhibitors of HIV-1 replication [corrected; erratum to be published] that inhibit HIV integrase.

Authors:  W E Robinson; M G Reinecke; S Abdel-Malek; Q Jia; S A Chow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

6.  Vinyl sulfones as mechanism-based cysteine protease inhibitors.

Authors:  J T Palmer; D Rasnick; J L Klaus; D Brömme
Journal:  J Med Chem       Date:  1995-08-18       Impact factor: 7.446

7.  Susceptibilities of simian immunodeficiency virus to protease inhibitors.

Authors:  Angelica C Giuffre; Joanne Higgins; Robert W Buckheit; Thomas W North
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

8.  Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study.

Authors:  C M Lin; S B Singh; P S Chu; R O Dempcy; J M Schmidt; G R Pettit; E Hamel
Journal:  Mol Pharmacol       Date:  1988-08       Impact factor: 4.436

9.  Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization.

Authors:  M Cushman; D Nagarathnam; D Gopal; A K Chakraborti; C M Lin; E Hamel
Journal:  J Med Chem       Date:  1991-08       Impact factor: 7.446

10.  Reversion of the M184V mutation in simian immunodeficiency virus reverse transcriptase is selected by tenofovir, even in the presence of lamivudine.

Authors:  Jeffrey P Murry; Joanne Higgins; Timothy B Matthews; Victoria Y Huang; Koen K A Van Rompay; Niels C Pedersen; Thomas W North
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  5 in total

1.  Metal-Free Synthesis of Functionalized Tetrasubstituted Alkenes by Three-Component Reaction of Alkynes, Iodine, and Sodium Sulfinates.

Authors:  Jitan Zhang; Zhenda Liang; Jun Wang; Ziyi Guo; Changqing Liu; Meihua Xie
Journal:  ACS Omega       Date:  2018-12-21

2.  The synthesis of chiral β-naphthyl-β-sulfanyl ketones via enantioselective sulfa-Michael reaction in the presence of a bifunctional cinchona/sulfonamide organocatalyst.

Authors:  Deniz Tözendemir; Cihangir Tanyeli
Journal:  Beilstein J Org Chem       Date:  2021-02-18       Impact factor: 2.883

3.  Chloroaluminate Ionic Liquid Immobilized on Magnetic Nanoparticles as a Heterogeneous Lewis Acidic Catalyst for the Friedel-Crafts Sulfonylation of Aromatic Compounds.

Authors:  Ngoc-Lan Thi Nguyen; Quoc-Anh Nguyen; Tien Khoa Le; Thi Xuan Thi Luu; Kim-Ngan Thi Tran; Phuoc-Bao Pham
Journal:  Molecules       Date:  2022-03-02       Impact factor: 4.411

4.  Electrochemical sulfonylation of alkenes with sulfonyl hydrazides: a metal- and oxidant-free protocol for the synthesis of (E)-vinyl sulfones in water.

Authors:  Yin-Long Lai; Yunyan Mo; Shaoxi Yan; Shengling Zhang; Lejie Zhu; Jianmin Luo; Huishi Guo; Jianpeng Cai; Jianhua Liao
Journal:  RSC Adv       Date:  2020-09-08       Impact factor: 4.036

5.  DABSO-based, three-component, one-pot sulfone synthesis.

Authors:  Alex S Deeming; Claire J Russell; Alan J Hennessy; Michael C Willis
Journal:  Org Lett       Date:  2013-12-05       Impact factor: 6.005

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.